At ECS.education, we’ve previously delved into how maternal metabolism and milk composition program infant development, the profound impact of maternal diet on the endocannabinoidome and infant health, and the links between ECS dysfunction, conditions like autism, and metabolic syndrome.
Today, we explore compelling new research that adds another crucial layer to this understanding: how a mother’s body fat levels (adiposity) can directly moderate the transfer of essential fatty acids into her milk, potentially steering it towards a more proinflammatory state and impacting the building blocks available for her infant’s developing endocannabinoid system.
The Vital Role of PUFAs: Fueling Growth and the Endocannabinoid System
Polyunsaturated fatty acids (PUFAs)—especially omega-3s like docosahexaenoic acid (DHA) and alpha-linolenic acid (ALA), and omega-6s like arachidonic acid (AA) and linoleic acid (LA)—are far more than just calories. For a growing infant, these bioactive molecules are critical for:
- Brain and eye development: DHA is a major structural component of the brain and retina.
- Immune system regulation: PUFAs help balance inflammatory responses.
- Overall growth and well-being.
Crucially, these PUFAs are also the precursors to endocannabinoids and related signaling lipids such as eicosanoids. For example, AA is the primary building block for key endocannabinoids like anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Omega-3s like DHA and EPA can also be converted into endocannabinoid-like compounds with unique regulatory roles. Thus, the PUFA profile of maternal milk directly influences the resources an infant has to establish and fine-tune their own ECS—a system vital for regulating appetite, mood, pain, and immune function.
New Research Shines Light: Maternal Adiposity as a Key Player
A recent study published in Scientific Reports by Zielinska-Pukos and colleagues (May 2025) provides striking insights into how maternal adiposity influences these vital milk components.
Study Snapshot: What Zielinska-Pukos et al. Discovered
The researchers conducted a case-control study comparing 20 mothers with healthy weight (HW) and 20 mothers with overweight or obesity (OW/OB) around 15 weeks postpartum. They analyzed dietary intake, serum fatty acid levels, and human milk fatty acid composition.
Here are some key takeaways:
- Different PUFA Profiles: Mothers with overweight/obesity had lower levels of serum arachidonic acid (AA) and, importantly, lower docosahexaenoic acid (DHA) in their human milk compared to healthy-weight mothers.
- Trans Fats: They also exhibited higher dietary intake and serum levels of trans fatty acids, which are generally associated with negative health outcomes.
- Proinflammatory Shift: The findings suggest that overweight and obesity can alter the fatty acid profile of human milk towards a more proinflammatory state.
- Not Just About Current Diet: Crucially, the study concluded that these obesity-related differences in human milk fatty acid profiles were not solely due to differences in current dietary intake between the groups.
The “Adiposity Filter”: How Body Fat Changes the Diet-to-Milk PUFA Pathway
Here’s where the study gets particularly intriguing. Maternal adiposity itself acts as a moderator in the transfer of fatty acids from diet to milk.
Higher maternal adiposity was found to negatively impact the association between dietary PUFA intake and human milk PUFA levels. This means that for mothers with more body fat, what they eat in the short term might not translate as efficiently into their milk’s PUFA content. Conversely, adiposity positively impacted the association between serum PUFA levels and human milk PUFA levels.
This suggests that in mothers with higher adiposity, their body’s existing fat stores and long-term metabolic status play a more dominant role in determining milk composition than their immediate diet. It points towards an altered metabolic handling or partitioning of these crucial fats. The researchers propose that human milk PUFA levels may be more influenced by long-term diet and body stores rather than short-term dietary changes.
Connecting the Dots: Milk PUFAs, Infant ECS Development, and Long-Term Health
These findings resonate deeply with our previous discussions on infant programming. If maternal milk—the infant’s sole or primary source of nutrition—has a suboptimal PUFA profile (e.g., lower DHA and a potentially proinflammatory omega-6 to omega-3 balance), what are the implications?
ECS Building Blocks
A reduced supply of essential PUFAs like AA and DHA directly impacts the availability of precursors for the infant’s developing endocannabinoid system. This could influence the tone and responsiveness of their ECS, with potential long-term consequences.
A Note on Serum vs. Tissue: Why It Matters for Endocannabinoids
It’s important to pause here and clarify what the study’s findings on serum arachidonic acid (AA) truly mean for infant health and the endocannabinoid system (ECS). While the researchers observed that mothers with higher adiposity had lower levels of AA in their serum, it’s crucial to understand that serum AA is not the direct precursor for endocannabinoid synthesis in the body.
Instead, the AA that serves as the building block for endocannabinoids like anandamide (AEA) and 2-AG is primarily stored within the membranes of our cells—especially in tissues such as the brain, immune system, and adipose tissue. Specialized enzymes release this tissue-bound AA when needed, fueling the production of these critical signaling molecules.
So, what does a lower serum AA level actually indicate? Rather than simply reflecting a reduced supply of ECS precursors, it points to altered maternal fatty acid metabolism—potentially involving increased storage of AA in adipose tissue, changes in how AA is converted from dietary sources, or a greater diversion of AA toward inflammatory pathways, all of which are more common in states of higher adiposity. This metabolic shift could, over time, affect the composition of fatty acids available for transfer into breast milk, subtly shaping the nutritional and signaling environment for the infant.
This distinction between serum and tissue AA is more than a technical detail; it’s a reminder of the complexity of fatty acid biology. It underscores why studies that only measure blood levels may not capture the full picture of how maternal diet and metabolism influence the ECS and, by extension, infant development.
Looking Ahead: Supporting Mothers and Optimizing Milk for a Healthy Start
The research by Zielinska-Pukos et al. is not about assigning blame; it’s about understanding complex biology to better support maternal and infant health.
Beyond Short-Term Diet: A Call for Holistic Maternal Metabolic Health
The key implication from this study is the call for specific dietary guidelines tailored for mothers with higher adiposity. It suggests that simply advising on short-term dietary changes during lactation might not be enough to overcome the metabolic influence of existing adiposity on milk composition.
Instead, the focus needs to broaden:
- Long-Term Dietary Quality: Emphasizing healthy, balanced diets rich in essential PUFAs before conception and throughout pregnancy becomes even more critical, as these long-term stores appear to significantly influence milk quality.
- Managing Adiposity: Supporting women in achieving and maintaining a healthy body weight before and during their reproductive years is paramount.
- Further Research: More research is needed to understand the precise mechanisms by which adiposity alters PUFA metabolism and transfer, and to develop targeted nutritional strategies that can effectively optimize milk composition in all mothers.
This study reinforces a central theme we often return to: maternal health is foundational to infant health. By understanding the intricate ways maternal metabolism, influenced by factors like adiposity, shapes the nutritional messages in breast milk, we can better empower mothers and work towards strategies that give every child the healthiest possible start, fostering a well-nourished body and a balanced endocannabinoid system right from the beginning.
Reference:
Zielinska-Pukos MA, Bryś J, Hamulka J. Maternal adiposity moderates associations between dietary, serum, and human milk n-3 and n-6 PUFA. Sci Rep. 2025;15(1):16489. Published 2025 May 12. doi:10.1038/s41598-025-00940-4
Comment
Comments are closed.